VPC
RGEN icon

Vestal Point Capital’s Repligen RGEN Stock Holding History

Vestal Point Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109M Buy
925,000
+842,000
+1,014% +$118M 3.05% 7
2025
Q4 		$13.6M Sell
83,000
-317,000
-79% -$49.7M 0.46% 44
2025
Q3 		$53.5M Buy
+400,000
New +$48.6M 2.41% 14

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vestal Point Capital's RGEN Position: Q1 2026 in Review

Vestal Point Capital increased its Repligen (RGEN) stake by 1,014% in Q1 2026, buying an estimated $118M and bringing the position to 925,000 shares worth $109M. The position accounts for 3.05% of the portfolio, ranked #7.

Vestal Point Capital first reported a position in RGEN in Q3 2025 and has held it in 3 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Vestal Point Capital held 925,000 shares of Repligen worth $109M as of Q1 2026.
  • Vestal Point Capital bought 842,000 Repligen shares in Q1 2026, an estimated $118M.
  • Repligen made up 3.05% of Vestal Point Capital's portfolio in Q1 2026, its #7 holding.
  • Vestal Point Capital first reported a position in Repligen in Q3 2025 and has held it in 3 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.